SOM Biotech
Spain - BarcelonaBiotechnology
Focus: SOM Biotech is a Barcelona-based biotech company specializing in drug repurposing with a focused pipeline in neurology, operating as a public-stage company founded in 2010.
Profile data last refreshed 14h ago · AI intelligence enriched 6d ago
Funding Stage
PUBLIC
Open Jobs
4
Should You Work at SOM Biotech?
AI assessmentSOM Biotech presents a specialized neurology play with repurposing expertise, but minimal hiring activity, early-stage pipeline, and opaque financials make it a high-risk career move for most professionals.
Why Work Here
- Specialized focus on drug repurposing in neurology offers deep expertise in an underexplored therapeutic model with potentially lower development risk.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Phase 1/2
Clinical Trials (1)
NCT02191826Study of SOM0226 in Familial Amyloid Polyneuropathy
Phase 1/2Help build intelligence for SOM Biotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.